IP Library › Granted Patent US 11,254,898
Granted Patent B2
US 11,254,898 · App. 16/258,560 · Granted Feb 22, 2022

Bioactive protein-polymer compositions

Inventors: Andreas Buthe (Steinfurt, DE); Ping Wang (North Oaks, MN); Songtao Wu (Ann Arbor, MI); Hongfei Jia (Ann Arbor, MI); Masahiko Ishii (Okazaki, JP); Minjuan Zhang (Ann Arbor, MI)
Assignees: Toyota Motor Corporation; Regents of the University of Minnesota
C11D3/38618C08G18/6225C08G18/792C09D175/04C11D3/04C11D3/044C11D3/2003C11D3/37C11D3/386C11D3/38627C11D7/04C11D7/261C11D11/0035
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,254,898
App. No.
16/258,560
Granted
Feb 22, 2022
Kind
B2
Abstract

Bioactive coatings that include a base and a protein associated with the base for actively promoting the removal of organic stains are provided. In aspects, bioactive coatings that are stabilized against inactivation by weathering are provided including a base associated with a chemically modified enzyme, and, optionally a first polyoxyethylene present in the base and independent of the enzyme. The coatings are optionally overlayered onto a substrate to form an active coating facilitating the removal of organic stains or organic material from food, insects, or the environment.

Claims (27)

1. A protein-polymer composition comprising:

a substrate or a coating formed of an a two component solvent borne crosslinked polymer resin comprising an aminoplast, melamine formaldehyde, carbamate, polyurethane, polyacrylate, epoxy, polycarbonate, alkyd, vinyl, polyamide, polyolefin, phenolic resin, polyester, polysiloxane, or combinations thereof; and

a plurality of bioactive proteins, said bioactive proteins associated with said substrate or coating in aggregates having an average diameter of 1 nanometer to 10 micrometers, and wherein the coating has a surface activity of 0.0075 units/cm′ or greater.

2. The composition of claim 1 wherein said bioactive proteins are entrapped within and crosslinked to said substrate or coating.

3. The composition of claim 1 wherein said bioactive protein is present at 0.1-50 weight percent of the total weight of said substrate or coating.

4. The composition of claim 1 wherein the bioactive protein is present at 1-20 weight percent of the total weight of the substrate or coating.

5. The composition of claim 1 wherein the bioactive protein is present at 2-8 weight percent of the total weight of the substrate or coating.

6. The composition of claim 1 wherein said polymer resin is the reaction product between a crosslinkable polymer comprising a reactive group selected from the group consisting of acetoacetate, acid, amine, carboxyl, epoxy, hydroxyl, isocyanate, silane, and vinyl;

and a crosslinker.

7. The composition of claim 6 wherein said reactive group is hydroxyl and said crosslinker is a polyisocyanate.

8. The composition of claim 1 wherein said bioactive protein is an enzyme.

9. The composition of claim 8 wherein said enzyme is a hydrolase.

10. The composition of claim 9 wherein said hydrolase is a protease, lipase, amylase, or combination thereof.

11. The composition of claim 1 wherein the average diameter is 1 nanometer to 5 micrometers.

12. The composition of claim 1 wherein the average diameter is 1 nanometer to 1 micrometer.

13. The composition of claim 1 further comprising one or more additives comprising a UV absorbing agent, a plasticizer, a wetting agent, a preservative, a surfactant, a lubricant, a pigment, a filler, and an additive suitable to increase sag resistance.

14. A protein-polymer composition comprising:

a substrate or a coating formed of an a two component solvent borne crosslinked polymer resin comprising an aminoplast, melamine formaldehyde, carbamate, polyurethane, polyacrylate, epoxy, polycarbonate, alkyd, vinyl, polyamide, polyolefin, phenolic resin, polyester, polysiloxane, or combinations thereof; and

a plurality of bioactive proteins, said bioactive proteins dispersed in said substrate or coating in aggregates having an average diameter of 1 nanometer to 5 micrometers,

wherein said bioactive proteins are entrapped within and crosslinked to said substrate or coating.

15. The composition of claim 14 wherein the average diameter does not exceed 5 micrometers.

16. The composition of claim 14 wherein the average diameter is 100 nanometers to 5 micrometers.

17. The composition of claim 14 wherein said bioactive protein is present at 0.1-50 weight percent of the total weight of said substrate or coating.

18. The composition of claim 14 wherein said polymer resin is the reaction product between a crosslinkable polymer comprising a reactive group selected from the group consisting of acetoacetate, acid, amine, carboxyl, epoxy, hydroxyl, isocyanate, silane, and vinyl;

and a crosslinker.

19. The composition of claim 18 wherein said reactive group is hydroxyl and said crosslinker is a polyisocyanate.

20. The composition of claim 14 wherein said bioactive proteins comprise a protease, lipase, amylase, or combination thereof.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC.
To: TOYOTA MOTOR CORPORATION
Reel/Frame 052156/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: BUTHE, ANDREAS; WANG, PING; WU, SONGTAO
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 048752/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: JIA, HONGFEI; ZHANG, MINJUAN
To: TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC.
Reel/Frame 048752/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2019
From: ISHII, MASAHIKO
To: TOYOTA MOTOR CORPORATION
Reel/Frame 048741/0872 →
Continuity (7)
Continuation 15810700 · Nov 13, 2017
Continuation In Part 15193242 · Jun 27, 2016
Continuation 13567341 · Aug 6, 2012
Continuation In Part 12820101 · Jun 21, 2010
Continuation In Part 14812087 · Jul 29, 2015
Continuation 13229277 · Sep 9, 2011
Related Publication 20190153359A1 · May 23, 2019
Cited By (1)
US 12,221,593